fda tirzepatide injection shortage resolved october 2 2024 confirms is still over, gives compounders a grace period Ozempic and Wegovy officially moved

Results at 48 weeks demonstrated dose-dependent weight loss with remarkable consistency

This "early worsening" phenomenon typically stabilizes with continued therapy but requires co-management with an ophthalmologist to determine appropriate individualized care

Yes, you can remain on the 5 mg dose of tirzepatide for three months if necessary because of satisfactory weight loss or intolerance to higher doses (Zepbound, FDA, 2025)

If needed, they may order a metabolic test to better understand your hormone and metabolic health or support insurance coverage

The 72-hour rule The FDA prescribing information states that if you want to change your injection day, you must ensure at least 3 days (72 hours) between doses

Before Your Appointment All patients should bank at least one feed before their appointment